Quimi Romar S.L.U. has been acquired by GPF Capital
GPF Capital, a private equity fund focused on investment in Spanish SMEs, has acquired Quimi Romar S.L.U. from Realza Capital and the founding family.
Established in 1968 in Valencia, Spain, Quimi Romar manufactures and distributes personal care, cosmetics and household cleaning products, both liquid and aerosol, mainly through owned brands. It markets over 750 products, which are sold through large distribution chains, discount and convenience retail stores, and traditional channels, with a large international presence.
GPF Capital is a private equity investment vehicle with over US$325 million under management. It has extensive experience and a solid track record in sectors that present opportunities for consolidation and growth. Since its inception in 2015, the firm has made over a dozen investments. This transaction fulfills GPF Capital’s interest in creating the national-leading player in the personal care, cosmetics and household cleaning segments, having simultaneously acquired another Spanish company in the sector.
Realza Capital is a private equity firm focused on making investments in Spanish mid-sized companies. The firm has more than US$325 million under management through two private equity funds.
Oaklins’ team in Spain provided strategic advisory services during a competitive auction process, acting as the exclusive financial advisor to Quimi Romar’s shareholders. The team assisted with the preparation of the sale process, structuring the transaction, identifying potential buyers, as well as the negotiations and closing procedures.
Talk to the deal team
Related deals
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn moreMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Learn more